PDS Planning, Inc

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 838618 DUBLIN, OH

Position in REGN

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$259,392

-$96,795 QoQ

Shares Held

416

-9.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#978

of 1,322 holders

Holding Since

Mar 2022

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PDS Planning, Inc holds $2,326,019 across 8 Biotechnology names. REGN ranks #4 (11.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,354	$672,572
2	ARGX	Argenx SE	394	$365,541
3	RPRX	Royalty Pharma plc	5,059	$283,658
4	REGN	Regeneron Pharmaceuticals, Inc. This page	416	$259,392
5	ARWR	Arrowhead Pharmaceuticals, Inc.	3,128	$254,963
6	HELP	Cybin Inc.	30,344	$200,573
7	GMAB	Genmab A/S	7,293	$200,338
8	RXRX	Recursion Pharmaceuticals, Inc.	24,246	$88,982

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$259,392	416	-9.8%	Shares	Sole	2026-08-05
2026-03-31	$356,187	461	+0.7%	Shares	Sole	2026-04-22
2025-12-31	$353,516	458	+2.9%	Shares	Sole	2026-01-26
2025-09-30	$250,210	445	+5.7%	Shares	Sole	2025-10-21
2025-03-31	$267,010	421	+24.6%	Shares	Sole	2025-04-24
2024-12-31	$240,767	338	-5.8%	Shares	Sole	2025-02-10
2024-09-30	$377,395	359	+0.8%	Shares	Sole	2024-10-30
2024-06-30	$374,166	356	+0.6%	Shares	Sole	2024-08-08
2024-03-31	$340,721	354	+5.0%	Shares	Sole	2024-05-01
2023-12-31	$295,983	337	-0.3%	Shares	Sole	2024-02-01
2023-09-30	$278,160	338	+8.3%	Shares	Sole	2023-10-23
2023-06-30	$224,184	312	-16.1%	Shares	Sole	2023-07-21
2023-03-31	$305,661	372	+4.8%	Shares	Sole	2023-05-02
2022-12-31	$256,128	355	-3.8%	Shares	Sole	2023-01-27
2022-09-30	$254,193	369	-0.3%	Shares	Sole	2022-11-02
2022-06-30	$218,718	370	+13.1%	Shares	Sole	2022-07-15
2022-03-31	$228,383	327	—	Shares	Sole	2022-04-18
No filing history on record for this holder in this stock.